EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Interpretable Machine Learning Model for Predicting 30‐Day Readmission in Advanced Heart Failure Patients: Synergistic Assessment of Inflammatory and Metabolic Biomarkers

Baohe Zang, Chengyu Li, Min Zhou, Yali Chao

Cardiovascular Therapeutics · 2026-01 · 2026 (1)

DOI: 10.1155/cdr/2307901 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Therapeutics, online erschienen am 08.03.2026. Verfasst von Baohe Zang und 3 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with advanced heart failure (AdHF) face a high risk of early readmission, leading to poor outcomes and increased healthcare burden. Early identification of high‐risk individuals remains a clinical challenge.

Methods

This retrospective study included 769 AdHF patients from the Affiliated Hospital of Xuzhou Medical University, with an independent external validation performed on a cohort of 495 AdHF patients from Shanghai Tenth People′s Hospital. After handling missing data via multiple imputation, the dataset was randomly split into training and validation sets in a 7:3 ratio. Class imbalance was addressed by applying the synthetic minority oversampling technique (SMOTE) exclusively within the training set, followed by the least absolute shrinkage and selection operator (LASSO)‐based feature selection. Seven machine learning models were developed. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), calibration curve, accuracy, sensitivity, specificity, F1 score, and Brier score, among others. SHAP values and a web‐based dynamic nomogram were used for model interpretation and clinical application.

Results

The 30‐day readmission rate was 30.9%. RF achieved the highest AUC (0.85), accuracy (0.79), and the lowest Brier score (0.159). Key predictors included C‐reactive protein (CRP), triglyceride‐glucose‐body mass index (TYG‐BMI), neutrophil‐to‐lymphocyte ratio (NLR), age, New York Heart Association (NYHA) class, atrial fibrillation (AF), comorbidity count, and angiotensin‐converting enzyme inhibitors/angiotensin receptor blockers/angiotensin receptor–neprilysin inhibitors (ACEI/ARB/ARNI) use. SHAP analysis confirmed the importance of inflammatory and metabolic markers. A web‐based nomogram was constructed to allow interactive risk prediction.

Conclusion

This study presents a robust and interpretable model for predicting a 30‐day readmission in AdHF patients, highlighting the role of inflammation, metabolism, and comorbidity burden. The model can assist clinicians in risk stratification and personalized postdischarge management.

Zitieren

APA

Zang, B., Li, C., Zhou, M., & Chao, Y. (2026). Interpretable Machine Learning Model for Predicting 30‐Day Readmission in Advanced Heart Failure Patients: Synergistic Assessment of Inflammatory and Metabolic Biomarkers. Cardiovascular Therapeutics, 2026(1). https://doi.org/10.1155/cdr/2307901

Vancouver

Zang B, Li C, Zhou M, Chao Y. Interpretable Machine Learning Model for Predicting 30‐Day Readmission in Advanced Heart Failure Patients: Synergistic Assessment of Inflammatory and Metabolic Biomarkers. Cardiovascular Therapeutics. 2026;2026(1). doi:10.1155/cdr/2307901

BibTeX
@article{Zang2026,
  author = {Zang, Baohe and Li, Chengyu and Zhou, Min and Chao, Yali},
  title = {Interpretable Machine Learning Model for Predicting 30‐Day Readmission in Advanced Heart Failure Patients: Synergistic Assessment of Inflammatory and Metabolic Biomarkers},
  journal = {Cardiovascular Therapeutics},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/cdr/2307901}
}
Kostenlos starten →